BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

5:47 PM
Feb 19, 2010
 |  BC Extra  |  Top Story

CHMP rebuffs ceftobiprole, J&J ends deal

Johnson & Johnson (NYSE:JNJ) returned to Basilea Pharmaceutica AG (SIX:BSLN) worldwide rights to ceftobiprole after the European Medicines Agency's CHMP issued a negative opinion to treat complicated skin and soft tissue infections (cSSTIs). The committee was concerned about the reliability of the data for ceftobiprole after...

Read the full 219 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >